Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 1;38(12):1801-1806.
doi: 10.1097/QAD.0000000000003952. Epub 2024 Aug 29.

Cancer in people with multidrug-resistant HIV

Tommaso Clemente  1   2 , Domenico Pontillo  2 , Vincenzo Malagnino  3 , Leonardo Calza  4 , Antonio Di Biagio  5   6 , Giovanni Cenderello  7 , Riccardo Lolatto  2 , Elio Manzillo  8 , Maria Cristina Moioli  9 , Giuseppe Vittorio De Socio  10 , Antonella Castagna  1   2 , Vincenzo Spagnuolo  2 ; the PRESTIGIO Study Group
Affiliations

Cancer in people with multidrug-resistant HIV

Tommaso Clemente et al. AIDS. .

Abstract

Retrospective, cohort analysis including people with HIV and 4-class drug resistance (4DR). The 8-year probability of malignancy after first evidence of 4DR was 12%, with an incidence of 1.6/100 person years of follow-up. Cancer risk tended to increase with higher precancer viremia copy-years adjusted for time [per 1 - log10 copies/ml higher: adjusted hazard ratio (aHR) = 1.35; 95% confidence interval (95% CI) = 0.98-1.85] and male sex-assigned-at-birth (aHR = 2.50; 95% CI = 0.86-7.27). Efforts to achieve long-term undetectability, risk factor control, prevention, and more aggressive cancer screening are needed in this fragile population.

PubMed Disclaimer

References

    1. Galli L, Parisi MR, Poli A, Menozzi M, Fiscon M, Garlassi E, et al. Burden of disease in PWH harboring a multidrug-resistant virus: data from the PRESTIGIO Registry . Open Forum Infect Dis 2020; 7:ofaa456.
    1. Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration . Lancet 2014; 384:241–248.
    1. Clemente T, Galli L, Lolatto R, Gagliardini R, Lagi F, Ferrara M, et al. Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors . BMJ Open 2024; 14:e080606.
    1. Greenberg L, Ryom L, Bakowska E, Wit F, Bucher HC, Braun DL, et al. Trends in cancer incidence in different antiretroviral treatment-eras amongst people with HIV . Cancers (Basel) 2023; 15:3640.
    1. Muchengeti M, Bohlius J, Dhokotera TG. Conjunctival cancer in people living with HIV . Curr Opin Infect Dis 2021; 34:1–7.

LinkOut - more resources